Upregulation of miR‐886 indicates poor prognosis and promotes tumour progression of prostate cancer

Volume: 54, Issue: 1
Published: Nov 17, 2021
Abstract
Prostate cancer is a heterogeneous disease with high incidence and mortality. The functional role of miR-886 has been reported in various cancers and its dysregulation in prostate cancer was also found. Whether miR-886 was involved in the development of prostate cancer remains unclear, which was explored. miR-886 was evaluated in prostate cancer by RT-qPCR, and its clinical value was also assessed. Additionally, the role of miR-886 in prostate...
Paper Details
Title
Upregulation of miR‐886 indicates poor prognosis and promotes tumour progression of prostate cancer
Published Date
Nov 17, 2021
Journal
Volume
54
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.